Yasunori Iwashima

Summary

Country: Japan

Publications

  1. ncbi Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages
    Y Iwashima
    Department of Internal Medicine, Sano Hospital, Suehiro 3 3 1 15, Asahikawa, 078 8133, Japan
    Biochem Biophys Res Commun 277:368-80. 2000
  2. ncbi Downregulation of the voltage-dependent calcium channel (VDCC) beta-subunit mRNAs in pancreatic islets of type 2 diabetic rats
    Y Iwashima
    Department of Internal Medicine, Sano Hospital, Suehiro 3 3 1 15, Asahikawa 078 8133, Japan
    Biochem Biophys Res Commun 280:923-32. 2001
  3. ncbi A case of type 2 diabetes with a large abscess of the gastric wall successfully treated with a glycemic control and systemic antibiotics
    Yasunori Iwashima
    Department of Internal Medicine, Yoshida Hospital, 4 Nishi 1 2, Asahikawa 070 0054, Japan
    Diabetes Res Clin Pract 69:299-304. 2005
  4. ncbi Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan
    Yasunori Iwashima
    Department of Internal Medicine, Yoshida Hospital, 4 Nishi 4 1 2, Asahikawa 070 0054, Japan
    Diabetes Res Clin Pract 74:8-14. 2006
  5. ncbi Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study
    Akizuki Morikawa
    Department of Internal Medicine, Asahikawa Red Cross Hospital, Akebono 1 1, Asahikawa 070 8530, Japan
    Clin Exp Nephrol 15:848-53. 2011

Collaborators

Detail Information

Publications5

  1. ncbi Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages
    Y Iwashima
    Department of Internal Medicine, Sano Hospital, Suehiro 3 3 1 15, Asahikawa, 078 8133, Japan
    Biochem Biophys Res Commun 277:368-80. 2000
    ..Thus, AGEs may be involved in the cause of variable levels of foam cell formation via the increased numbers of OxLDL receptors in accelerated atherosclerotic lesions of individuals with diabetes...
  2. ncbi Downregulation of the voltage-dependent calcium channel (VDCC) beta-subunit mRNAs in pancreatic islets of type 2 diabetic rats
    Y Iwashima
    Department of Internal Medicine, Sano Hospital, Suehiro 3 3 1 15, Asahikawa 078 8133, Japan
    Biochem Biophys Res Commun 280:923-32. 2001
    ....
  3. ncbi A case of type 2 diabetes with a large abscess of the gastric wall successfully treated with a glycemic control and systemic antibiotics
    Yasunori Iwashima
    Department of Internal Medicine, Yoshida Hospital, 4 Nishi 1 2, Asahikawa 070 0054, Japan
    Diabetes Res Clin Pract 69:299-304. 2005
    ..Thus, a tight glycemic control and awareness of this disease should be reemphasized, and this may improve the prognosis of this rare and fatal one, even a poorly-controlled diabetes...
  4. ncbi Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan
    Yasunori Iwashima
    Department of Internal Medicine, Yoshida Hospital, 4 Nishi 4 1 2, Asahikawa 070 0054, Japan
    Diabetes Res Clin Pract 74:8-14. 2006
    ..020, 0.031 and 0.043). The present study thus revealed that candesartan effectively induced regression of LVH in type 2 diabetic patients with hypertension due to effects beyond reduction in BP...
  5. ncbi Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study
    Akizuki Morikawa
    Department of Internal Medicine, Asahikawa Red Cross Hospital, Akebono 1 1, Asahikawa 070 8530, Japan
    Clin Exp Nephrol 15:848-53. 2011
    ..The aim of his study was to compare the efficacy of pioglitazone with metformin on the reduction of albuminuria in type 2 diabetic patients with hypertension and microalbuminuria treated with renin-angiotensin system inhibitors (RAS-Is)...